Biochemical properties of inducible beta-lactamases produced from Xanthomonas maltophilia

R Paton1, R S Miles, S G Amyes

  • 1Department of Medical Microbiology, Medical School, University of Edinburgh, United Kingdom.

Insights

Xanthomonas maltophilia produces multiple beta-lactamases, including a metallo-beta-lactamase and others with broad-spectrum activity. These enzymes exhibit varied resistance to inhibitors and hydrolysis profiles, expanding known resistance mechanisms.

Area of Science:

  • Microbiology
  • Biochemistry
  • Enzymology

Background:

  • Xanthomonas maltophilia is an opportunistic pathogen.
  • Beta-lactamase production is a key mechanism of antibiotic resistance in bacteria.
  • Previous studies identified L1 and L2 beta-lactamases in X. maltophilia.

Purpose of the Study:

  • To characterize the beta-lactamases produced by X. maltophilia strains.
  • To investigate the enzymatic properties and inhibitor profiles of these beta-lactamases.

Main Methods:

  • Isolation and characterization of beta-lactamases from X. maltophilia blood culture isolates.
  • Isoelectric focusing (IEF) to determine isoelectric points (pI).
  • Gel filtration and SDS-PAGE for molecular size determination.
  • Enzyme activity assays against various beta-lactam antibiotics.
  • Inhibition studies with specific inhibitors (e.g., EDTA, clavulanate).

Main Results:

  • Four distinct beta-lactamases were identified.
  • A metallo-beta-lactamase (pI 6.8) showed penicillinase activity, hydrolyzed most beta-lactams except aztreonam, and was inhibited by heavy metals and EDTA.
  • Other beta-lactamases (pI 5.2-6.6) had broad-spectrum activity against most beta-lactams (except imipenem, aztreonam) and were inhibited by clavulanate and BRL 42715.
  • Molecular weight discrepancies between gel filtration and SDS-PAGE suggested oligomeric structures.

Conclusions:

  • X. maltophilia produces a diverse array of beta-lactamases beyond the previously identified L1 and L2.
  • The characterized enzymes possess distinct biochemical properties and resistance profiles, contributing to the pathogen's antibiotic resistance.
  • Understanding these enzymes is crucial for developing effective therapeutic strategies against X. maltophilia infections.

Related Concept Videos

Inducible Operons: lac Operon01:25

Inducible Operons: lac Operon

The lac operon in Escherichia coli is a model for understanding inducible gene regulation and metabolic flexibility. It integrates local control by lactose and global regulation through catabolite repression, enabling E. coli to preferentially metabolize glucose when available and switch to lactose utilization when glucose is scarce.Structure and Function of the lac OperonThe lac operon contains three structural genes: lacZ (β-galactosidase), lacY (lactose permease), and lacA (thiogalactoside...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...